SCHEMBL22858487

SCHEMBL22858487

CNc1ncnc2c1ccn2I

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
YTHDC1 Q96MU7 2/20 0.42
TP53 P04637 2/20 0.41
LMNA P02545 1/20 0.41
PRMT5 O14744 3/20 0.40
WDR77 Q9BQA1 3/20 0.40
PDPK1 O15530 1/20 0.40
MAP4K4 O95819 2/20 0.38
ABL1 P00519 1/20 0.37
BCR P11274 1/20 0.37
EGFR P00533 1/20 0.36
SRC P12931 1/20 0.36
KDM4E B2RXH2 1/20 0.36
MEN1 O00255 1/20 0.36
ALDH1A1 P00352 1/20 0.36
KMT2A Q03164 1/20 0.36
GRM1 Q13255 2/20 0.35
CYP1A2 P05177 1/20 0.34
CYP3A4 P08684 1/20 0.34
CYP2D6 P10635 1/20 0.34
TSHR P16473 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18572173 0.80 ABL1 (0.54) YTHDC1TP53LMNAPRMT5WDR77
SCHEMBL22509955 0.79 PDPK1 (0.43) YTHDC1TP53LMNAPRMT5WDR77
SCHEMBL23898962 0.79 YTHDC1 (0.42) YTHDC1TP53LMNAPRMT5WDR77
SCHEMBL21473730 0.77 CCNB2 (0.43) YTHDC1TP53LMNAPRMT5WDR77
SCHEMBL22521390 0.76 YTHDC1 (0.40) YTHDC1TP53LMNAPRMT5WDR77
SCHEMBL24720081 0.76 PRMT5 (0.44) YTHDC1TP53LMNAPRMT5WDR77
SCHEMBL24205545 0.75 PRMT5 (0.48) YTHDC1TP53LMNAPRMT5WDR77
SCHEMBL22508902 0.72 SLC22A12 (0.44) PRMT5WDR77SRCMEN1ALDH1A1
SCHEMBL24205320 0.71 PDPK1 (0.41) YTHDC1TP53LMNAPRMT5WDR77
SCHEMBL20041716 0.69 YTHDC1 (0.66) YTHDC1PDE5APDE4APDE1APDE1B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210002720-A1 DNA SEQUENCING REACTION ADDITIVE IsoPlexis Corporation 2021-01-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210002720-A1 DNA SEQUENCING REACTION ADDITIVE RNGTT, NSUN2, NT5C3B YTHDC1 631/4885TP53 975/4885LMNA 3089/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.